New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
0
1

Coils implanted into lungs show promise for emphysema

Implanting tiny coils in the lungs of patients with severe emphysema improves exercise capacity at six months, although the short term costs of treatment are high, researchers have reported in JAMA.1  
feeds.bmj.com
over 3 years ago
Preview
0
0

Coils implanted into lungs show promise for emphysema

Implanting tiny coils in the lungs of patients with severe emphysema improves exercise capacity at six months, although the short term costs of treatment are high, researchers have reported in JAMA.1  
feeds.bmj.com
over 3 years ago
Preview
0
0

Organ transplantation may link to deaths from cancer, study finds

Patients who receive kidney, liver, heart, or lung transplants are at higher risk of dying from cancer than the general population, research published in JAMA Oncology has found.1  
feeds.bmj.com
over 3 years ago
Preview
0
0

ELF5 Protein Tied to Lung Metastasis in Breast Cancer

ELF5, a protein that controls milk production in the breast after pregnancy can go rogue in breast cancer and prompt spreading to the lungs, according to international investigators.  
medscape.com
over 3 years ago
Preview
0
0

Early-Life Organophosphate Exposure and Later Impaired Lung Function

Exposure to organophosphate (OP) pesticides in the first few years of life is associated with impaired lung function at age 7, researchers report.  
medscape.com
over 3 years ago
Preview
0
0

Smokers urged to quit in 2016 to avoid lung disease - BBC News

Public Health England is urging smokers to quit their habit in 2016 to avoid developing serious lung conditions that can be debilitating.  
bbc.co.uk
over 3 years ago
Preview
0
1

Cancer of Unknown Primary Increases Cancer Risks

First-degree relatives of people with cancer of unknown primary are at greater risk for cancer of an unknown primary, as well as cancers of the lung, pancreas, and colon and rectum.  
medscape.com
over 3 years ago
Preview
0
2

Newer Spirometry Reference Standards Can Improve Asthma Treatment

Switching from the older Zapletal reference values to the newer Global Lung Function Initiative (GLI) values can result in improved asthma treatment, researchers report.  
medscape.com
over 3 years ago
Preview
0
0

News Quiz: 2015 an Important Year for the Lungs

New drugs for COPD, asthma, and cystic fibrosis made headlines this year. Experts debated the apnea treatment vacuum and what to do about tricky pulmonary fibrosis and contaminated bronchoscopes. Test how well you kept up with the news this year  
medscape.com
over 3 years ago
Preview
0
0

Updates in Nontuberculous Mycobacterial Lung Infections

Lung diseases caused by nontuberculous mycobacteria are seldom effectively diagnosed and promptly treated.  
medscape.com
over 3 years ago
Preview
0
2

Pulmonary Hypertension No Bar to Single-Lung Transplant

Pulmonary hypertension (PH) does not significantly affect outcome of single-lung transplantation, possibly increasing the number of potential recipients, according to Wisconsin-based researchers.  
medscape.com
almost 4 years ago
Preview
0
2

UNOS Approves Child Priority Policy for Lung Transplant

The U.S. Organ Procurement and Transplantation Network (OPTN) and the United Network for Organ Sharing (UNOS) Board of Directors revised its pediatric lung allocation policy at its December 1-2 meeting.  
medscape.com
almost 4 years ago
Preview
6
392

Pneumothorax: Practice Essentials, Background, Anatomy

Pneumothorax is defined as the presence of air or gas in the pleural cavity (ie, the potential space between the visceral and parietal pleura of the lung). The clinical results are dependent on the degree of collapse of the lung on the affected side.  
emedicine.medscape.com
almost 4 years ago
Preview
0
3

Optimizing the Management of Advanced Squamous Cell Carcinoma of the Lung CME

This activity is intended for hematologists and oncologists who manage patients with advanced squamous cell carcinoma of the lung  
medscape.org
almost 4 years ago
Preview
0
6

Prenatal treatments for babies with congenital diaphragmatic hernia | Cochrane

A congenital diaphragmatic hernia (CDH) is a hole in the diaphragm, the muscle that helps with breathing and separates the chest and abdomen. This defect can allow the liver and bowel to move to the chest cavity and interfere with lung development, affecting lung and heart function in newborn babies. At birth, respiratory insufficiency and pulmonary hypertension contribute to poor outcomes. About one in every 3000 babies may be affected and the problem can be diagnosed during a routine mid-pregnancy ultrasound at around 20 weeks. For babies born with a CDH, surgery in early life is necessary, but even with new surgical techniques there can be a poor outlook and many long-term medical problems. Treatments are now possible in pregnancy. Interventions described to date include maternal antenatal corticosteroid administration and prenatal tracheal occlusion to improve lung growth and maturity by obstruction of the fetal trachea. This increases airway pressure by preventing secreted lung fluid from leaving the lungs resulting in growth and expansion of the lungs. There are potential side effects and complications for the mother with this procedure as the uterus and amniotic sac are entered in order to gain access to the unborn baby.  
cochrane.org
almost 4 years ago
Preview
0
3

The lung study promising a breath of fresh air in research world

Researchers see it as a test bed for “real world” trials that could lead to the quicker introduction of drugs and medical devices. The Salford Lung Study is examining the safety and effectiveness of a new treatment for chronic obstructive pulmonary disease (COPD) in 80 general practices around Salford in north west England.1 About 2500 patients are participating, half randomised to a new inhalation powder Relvar Ellipta (fluticasone furoate/vilanterol) and half to usual treatment.  
feeds.bmj.com
almost 4 years ago
Preview
0
0

The lung study promising a breath of fresh air in research world

Researchers see it as a test bed for “real world” trials that could lead to the quicker introduction of drugs and medical devices. The Salford Lung Study is examining the safety and effectiveness of a new treatment for chronic obstructive pulmonary disease (COPD) in 80 general practices around Salford in north west England.1 About 2500 patients are participating, half randomised to a new inhalation powder Relvar Ellipta (fluticasone furoate/vilanterol) and half to usual treatment.  
feeds.bmj.com
almost 4 years ago
Preview
0
1

Targeting IL13Ralpha2 to Suppress Breast Cancer Lung Metastasis

Learn more about novel genes that drive metastasis of BLBC and elucidate the underlying mechanisms of action.  
medscape.com
almost 4 years ago
Preview
0
0

Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

Serological and proteomic biomarkers can help clinicians diagnose rheumatic diseases earlier and assess disease activity more accurately. These markers have been incorporated into the recently revised classification criteria of several diseases to enable early diagnosis and timely initiation of treatment. Furthermore, they also facilitate more accurate subclassification and more focused monitoring for the detection of certain disease manifestations, such as lung and renal involvement. These biomarkers can also make the assessment of disease activity and treatment response more reliable. Simultaneously, several new serological and proteomic biomarkers have become available in the routine clinical setting—for example, a protein biomarker panel for rheumatoid arthritis and a myositis antibody panel for dermatomyositis and polymyositis. This review will focus on commercially available antibody and proteomic biomarkers in rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis (scleroderma), dermatomyositis and polymyositis, and axial spondyloarthritis (including ankylosing spondylitis). It will discuss how these markers can facilitate early diagnosis as well as more accurate subclassification and assessment of disease activity in the clinical setting. The ultimate goal of current and future biomarkers in rheumatic diseases is to enable early detection of these diseases and their clinical manifestations, and to provide effective monitoring and treatment regimens that are tailored to each patient’s needs and prognosis.  
feeds.bmj.com
almost 4 years ago
Preview
0
0

Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

Serological and proteomic biomarkers can help clinicians diagnose rheumatic diseases earlier and assess disease activity more accurately. These markers have been incorporated into the recently revised classification criteria of several diseases to enable early diagnosis and timely initiation of treatment. Furthermore, they also facilitate more accurate subclassification and more focused monitoring for the detection of certain disease manifestations, such as lung and renal involvement. These biomarkers can also make the assessment of disease activity and treatment response more reliable. Simultaneously, several new serological and proteomic biomarkers have become available in the routine clinical setting—for example, a protein biomarker panel for rheumatoid arthritis and a myositis antibody panel for dermatomyositis and polymyositis. This review will focus on commercially available antibody and proteomic biomarkers in rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis (scleroderma), dermatomyositis and polymyositis, and axial spondyloarthritis (including ankylosing spondylitis). It will discuss how these markers can facilitate early diagnosis as well as more accurate subclassification and assessment of disease activity in the clinical setting. The ultimate goal of current and future biomarkers in rheumatic diseases is to enable early detection of these diseases and their clinical manifestations, and to provide effective monitoring and treatment regimens that are tailored to each patient’s needs and prognosis.  
feeds.bmj.com
almost 4 years ago